Alliance 12F - Wesley Research Institute
Wesley Research Institute
Donate
Now

The objective of this study is to demonstrate the safety and functionality of the Edwards 12F Sheath Introducer Set in conjunction with the Edwards SAPIEN X4 THV in subjects with symptomatic, severe, calcific AS. 

Research Objectives

Status

Current

Recruitment

Open

Total participants required

5

Study location

Wesley Research Institute & St Andrew's War Memorial Hospital

Study type

Industry Sponsored

Patient group

People with severe aortic stenosis otherwise known as narrowing or constriction of their aortic valve may be eligible for this trial.

About this clinical trial

This study investigates the safety and efficacy of the Edwards 12F Sheath Introducer Set, a new and smaller sheath designed for transcatheter aortic valve replacement (TAVR) procedures. Researchers aim to determine whether the Edwards 12F Sheath can effectively deliver the Edwards SAPIEN X4 THV, a type of artificial aortic valve, while reducing the risk of vascular complications associated with TAVR. If successful, the Edwards 12F Sheath could offer a safer and more effective option for TAVR, improving the treatment of AS and potentially reducing the burden of this common valvular disease. 

Eligibility

1. Severe, calcific Aortic Stenosis  

2. Aortic size suitable for SAPIEN X4 Transcatheter Heart Valve 

3. The subject has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent. 

Lead investigators

  • Dr Karl Poon
  • Dr Alexander Incani

Clinical trial coordinator

  • Linda Pearce

Technical title

Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve

Contact for more information

If you would like more information about this clinical trial, please complete the contact form below.

Name
I consent to receive updates on Wesley Research Institute news and events, clinical trials, research projects and how to support WRI.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram